Publications 2012
Albayram O, Bilkei-Gorzo A, Zimmer A. (2012). Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory. Front Aging Neurosci, 4:34. doi: 10.3389/fnagi.2012.00034.
Bénard G, Massa F, Puente N, Lourenço J, Bellocchio L, Soria-Gómez E, Matias I, Delamarre A, Metna-Laurent M, Cannich A, Hebert-Chatelain E, Mulle C, Ortega-Gutiérrez S, Martín-Fontecha M, Klugmann M, Guggenhuber S, Lutz B, Gertsch J, Chaouloff F, López-Rodríguez ML, Grandes P, Rossignol R, Marsicano G. (2012). Mitochondrial CB₁ receptors regulate neuronal energy metabolism. Nat Neurosci, 15(4):558-64.
Díaz-Alonso J, Aguado T, Wu CS, Palazuelos J, Hofmann C, Garcez P, Guillemot F, Lu HC, Lutz B, Guzmán M, Galve-Roperh I. (2012). The CB1 Cannabinoid Receptor Drives Corticospinal Motor Neuron Differentiation through the Ctip2/Satb2 Transcriptional Regulation Axis. J Neurosci, 32(47):16651-16665.
Häring M, Guggenhuber S, Lutz B. (2012). Neuronal populations mediating the effects of endocannabinoids on stress and emotionality. Neuroscience, 204:145-58.
Rey AA, Purrio M, Viveros MP, Lutz B. (2012). Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABA(B) Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission. Neuropsychopharmacology, 37(12):2624-34.
Ruehle S, Rey AA, Remmers F, Lutz B. (2012). The endocannabinoid system in anxiety, fear memory and habituation. J Psychopharmacol, 26(1):23-39.
Häring M, Grieb M, Monory K, Lutz B, Moreira FA. (2012). Cannabinoid CB(1) receptor in the modulation of stress coping behavior in mice: The role of serotonin and different forebrain neuronal subpopulations. Neuropharmacology, 65C:83-89.
Bilkei-Gorzo A. (2012). The endocannabinoid system in normal and pathological brain ageing. Phil Trans R Soc B, 367, 3326-3341.
Rácz I, Markert A, Mauer D, Stoffel-Wagner B, Zimmer A. (2012). Long-term ethanol effects on acute stress responses: modulation by dynorphin. Addict Biol, doi: 10.1111/j.1369-1600.2012.00494.
Janzer A, Stamm K, Becker A, Zimmer A, Buettner R, Kirfel J. (2012). The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology and the metabolome of fibroblasts. J Biol Chem, 287:30984-30992.
Miró X, Meier S, Dreisow ML, Frank J, Strohmaier J, Breuer R, Schmäl C, Albayram O, Pardo-Olmedilla MT, Mühleisen TW, Degenhardt FA, Mattheisen M, Reinhard I, Bilkei-Gorzo A, Cichon S, Seidenbecher C, Rietschel M, Nöthen MM, Zimmer A. (2012). Studies in humans and mice implicate neurocan in the etiology of mania. Am J Psychiatry,169(9):982-90.
Malinowska B, Baranowska-Kuczko M, Schlicker E (2012). Triphasic blood pressure responses to cannabinoids: do we understand the mechanism? Brit J Pharmacol, 165(7):2073-88.
Poppensieker K, Otte DM, Schürmann B, Limmer A, Dresing P, Drews E, Schumak B, Klotz L, Raasch J, Mildner A, Waisman A, Scheu S, Knolle P, Förster I, Prinz M, Maier W, Zimmer A, Alferink J. (2012). CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells. Proc Natl Acad Sci U S A, 109(10): 3897-3902.
Sugawara K, Bíró T, Tsuruta D, Tóth BI, Kromminga A, Zákány N, Zimmer A, Funk W, Gibbs BF, Zimmer A, Paus R. (2012). Endocannabinoids limit excessive mast cell maturation and activation in human skin. J Allergy Clin Immunol, 129(3):726-738.e8.
Wojtalla A, Herweck F, Granzow M, Klein S, Trebicka J, Huss S, Lerner R, Lutz B, Schildberg FA, Knolle PA, Sauerbruch T, Singer MV, Zimmer A, Siegmund SV. (2012). The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells, but not in hepatocytes. Am J Physiol Gastrointest Liver Physiol, 302: G873–G887.
Lupinski SL, Schlicker E, Pędzinska-Betiuk A, Malinowska B (2012). Acute myocardial ischemia enhances the vanilloid TRPV1 and serotonin 5-HT3 receptor-mediated Bezold-Jarisch reflex in rats. Pharmacol Rep, 63(6):1450-9.
Schulte K, Steingrüber N, Jergas B, Redmer A, Kurz CM, Buchalla R, Lutz B, Zimmer A, Schlicker E (2012). Cannabinoid CB1 receptor activation, pharmacological blockade or genetic ablation affects the function of the muscarinic auto- and heteroreceptor. Naunyn-Schmiedeberg´s Arch Pharmacol, 385(4):385-96.